Cargando…

Baseline urinary KIM-1 concentration in detecting acute kidney injury should be interpreted with patient pre-existing nephropathy

OBJECTIVES: To determine whether pre-existing nephropathy impacts urinary KIM-1 levels, urinary KIM-1 were measured in patients with normal kidney filtration function but either with or without proteinuria. The reference intervals of urinary KIM-1 in adults with normal kidney filtration function but...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yun, Tian, Yuan, Likhodii, Sergei, Randell, Edward
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447747/ https://www.ncbi.nlm.nih.gov/pubmed/30989103 http://dx.doi.org/10.1016/j.plabm.2019.e00118

Ejemplares similares

KIM-1 and NGAL: new markers of obstructive nephropathy
por: Wasilewska, Anna, et al.
Publicado: (2011)

Potential Role and Excretion Level of Urinary Transferrin, KIM-1, RBP, MCP-1 and NGAL Markers in Diabetic Nephropathy
por: Siddiqui, Khalid, et al.
Publicado: (2020)

Kim /
por: Kipling, Rudyard, 1865-1936
Publicado: (1999)

Kim /
por: Kipling, Rudyard, 1865-1936
Publicado: (1986)

Hyperglycemia-related advanced glycation end-products is associated with the altered phosphatidylcholine metabolism in osteoarthritis patients with diabetes
por: Zhang, Weidong, et al.
Publicado: (2017)

Assay Validation for KIM-1: human urinary renal dysfunction biomarker
por: Chaturvedi, Shalini, et al.
Publicado: (2009)

In-silico analysis of interacting pathways through KIM-1 protein interaction in diabetic nephropathy
por: Abid, F., et al.
Publicado: (2022)

Urinary calprotectin, NGAL, and KIM-1 in the differentiation of primarily inflammatory vs. non-inflammatory stable chronic kidney diseases
por: Seibert, Felix S., et al.
Publicado: (2021)

Glycemic Variability and KIM-1–Induced Inflammation in the Diabetic Kidney
por: Tuttle, Katherine R., et al.
Publicado: (2021)

Correction: In-silico analysis of interacting pathways through KIM-1 protein interaction in diabetic nephropathy
por: Abid, F., et al.
Publicado: (2022)

Urinary KIM-1: a novel biomarker for evaluation of occupational exposure to lead
por: Zhou, Rong, et al.
Publicado: (2016)

Day-to-day variation of the kidney proximal tubular injury markers urinary cystatin C, KIM1, and NGAL in patients with chronic kidney disease
por: Soveri, Inga, et al.
Publicado: (2020)

Diagnostic Performance of Biomarkers Urinary KIM-1 and YKL-40 for Early Diabetic Nephropathy, in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
por: Kapoula, Georgia V., et al.
Publicado: (2020)

Value of urinary KIM-1 and NGAL combined with serum Cys C for predicting acute kidney injury secondary to decompensated cirrhosis
por: Lei, Lei, et al.
Publicado: (2018)

Differential metabolomics networks analysis of menopausal status
por: Cui, Xiujuan, et al.
Publicado: (2019)

Kim il sung : biography (II)
por: Bong, Baik
Publicado: (1970)

Kim il sung : biography (II)
por: Bong, Baik
Publicado: (1970)

A Phage Display-Identified Peptide Selectively Binds to Kidney Injury Molecule-1 (KIM-1) and Detects KIM-1–Overexpressing Tumors In Vivo
por: Haque, Md. Enamul, et al.
Publicado: (2019)

Urinary Biomarkers KIM-1 and NGAL for Detection of Chronic Kidney Disease of Uncertain Etiology (CKDu) among Agricultural Communities in Sri Lanka
por: De Silva, Pallagae Mangala C. S., et al.
Publicado: (2016)

Evidence of kidney injury in preeclampsia: Increased maternal and urinary levels of NGAL and KIM-1 and their enhanced expression in proximal tubule epithelial cells
por: Wang, Yuping, et al.
Publicado: (2023)

In Memory of Chong-Sun Kim
por: Oh, Seung-Ha
Publicado: (2020)

Kim Zong Il : dirigente del pueblo
por: Che In Su
Publicado: (1983)

Diagnostic roles of urinary kidney microvesicles in diabetic nephropathy
por: Cai, Fang-Hao, et al.
Publicado: (2020)

The Predicted Value of Kidney Injury Molecule-1 (KIM-1) in Healthy People
por: Peng, Shanshan, et al.
Publicado: (2022)

Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases
por: Klavdianou, Kalliopi, et al.
Publicado: (2021)

A classification modeling approach for determining metabolite signatures in osteoarthritis
por: Rockel, Jason S., et al.
Publicado: (2018)

Urinary KIM-1 Correlates with the Subclinical Sequelae of Tubular Damage Persisting after the Apparent Functional Recovery from Intrinsic Acute Kidney Injury
por: Cuesta, Cristina, et al.
Publicado: (2022)

Chrysospleniumramosissimum Y.I.Kim & Y.D.Kim (Saxifragaceae), a new species from Korea
por: Kim, Yong-In, et al.
Publicado: (2018)

Urinary KIM-1 is not correlated with gestational age among 5-year-old children born prematurely
por: Restrepo, Jaime M., et al.
Publicado: (2023)

Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know?
por: Sharma, Praveen, et al.
Publicado: (2021)

Cherishing the memory of Professor Sang-In Kim
por: Kwon, Seog-Woon
Publicado: (2011)

In Memory of Soon Yong Kim, MD
por: Lim, Jae Hoon
Publicado: (2014)

In Memory of Professor Chu-Wan Kim
por: Lee, Jae Young
Publicado: (2015)

Isaac McKim McCurley
Publicado: (1869)

Speaker 4: Kim Do,Switzerland
por: Dwir, Daniella, et al.
Publicado: (2016)

First person – Kim Anh Nguyen
Publicado: (2019)

Clinical significance of NGAL and KIM-1 for acute kidney injury in patients with scrub typhus
por: Sun, In O., et al.
Publicado: (2017)

Evaluation of NAG, NGAL, and KIM-1 as Prognostic Markers of the Initial Evolution of Kidney Transplantation
por: Tabernero, Guadalupe, et al.
Publicado: (2023)

A study of the utility of novel non-invasive urinary and serum biomarkers of blunt kidney injury in a rat model: NGAL, KIM-1, and IL-18
por: Bakal, Ünal, et al.
Publicado: (2019)

Urinary Biomarkers of Renal Injury KIM-1 and NGAL: Reference Intervals for Healthy Pediatric Population in Sri Lanka
por: De Silva, P. Mangala C. S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j4u8poukie5p5bmu6hmhs8bg8g